Half-year report · Q2
3747.TEDINET S100VRG8
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥863m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥940m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥16m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥62m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥85m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥160m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥27m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥38m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥32m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥40m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥98m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥49m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥17m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥411m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥413m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥819m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥819m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥994m | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥81m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥106m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥202m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥124m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥73m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.53 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.63 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.82 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥162m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥21m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥224m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥24m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥178m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥151m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥5m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥240m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥22m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥213m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)木 村 直 人 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)加 藤 大 佑 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 940343000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 862797000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1849078000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -26595000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -85454000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -159583000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 20244000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -39755000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -97904000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 17395000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -48789000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -97697000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 1347924000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 1184028000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1232832000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 1707616000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 1594983000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1645970000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 2.82 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -5.53 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -13.63 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.784 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.741 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.742 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 105542000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 20158000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 81478000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -15967000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -202414000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -124252000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -13622000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -24090000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 73315000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1070332000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 818576000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1024922000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 7444800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 7444800 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 7444800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 7444800 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 1346400 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1874 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |